EthocynProducts.com


Results of this study were presented at the International Society for Androgenic Disorders Symposium, the 1995 meeting of the Dermatology Therapy Association, the UCLA Conferences on Aging, and the St. Johns Hospital Dermatology Grand Rounds.
PT. # SEX AGE % MONTH 0 % MONTH 1 % MONTH 2 % MONTH 3 L. CHEEK R. CHEEK
1(TM) M 48 3.5 8.9 17.6 19.8 better worse
2(DK) M 77 7.9 11.1   20.8 worse no change
3(MK) F 72 20.3 21.2   31.5 no change better
4(JR) F 48 7.3 18.4 24.4 28.2 better worse
5(LS) F 46 5.7 12.8 17.8 23.7 better better
6(MM) F 52 9.6 15.1 15.8 26.1 better better
8(DY) F 42 9.9 15.3 16.9 24.2 better better
10(SY) F 47 3.6 8.6 20.4 12 better better
11(DH) M 47 6.9 11.2 13.6 18 better no change
12(PH) F 43 9.3 11.9 17.4 25.6 better better
13(SA) F 42 3.3 10.7 16.7 13.9 worse worse
14(CB) F 45 6.8 9.3 14.2 20.4 better better
15(KR) F 49 6.3 12.2 16.9 23.1 better better
16(SP) F 46 8.1 14.9 18.8 20.2 better better
17(LY) M 50 3.8 9.7 10.7 10.8 no change better
18(JN) F 60 11.1 16.9 20.1 15.2 better better
19(DL) M 44 6.2 16.3 17.7 21.3 better worse
20(DD) F 50 6.3 15.1 27.2 26.1 better better
21(JS) F 40 4 6.9 12.1 25.6 better better
22(JD) M 43 5.6 6.7 9.8 20.5 better better
23(RS) F 47 8 11.8 17.1 20.1 no change better
24(SR) M 53 9.5 10.4 14.7 23.9 better better
25(MF) F 63 10.5 14.7 22.3 26.3 better better
26(KF) F 42 3.9 8.1 10.7 17.6 better better
27(DM) F 45 7.8 8.6 14.9 17.8 worse no change
28(SU) F 43 9.8 9.6 17.6 20.2 no change no change
30(MY) F 45 19 18.4 30.2 23.6 better better
31(MJ) F 49 10.2 13 15.1 20.7 worse better
32(HS) M 48 10.2 12.5 20.9 21.4 no change no change
MEAN   49 8.1 12.4 17.5 21.3    
P-VALUE       p<.001 p<.001 p<.001 p=.001  

back to top